Opinion|Videos|May 22, 2024

Key Takeaways Following MAJIC-PV

Gabriela Hobbs, MD, and Timothy Mok, PharmD, BCPS, BCOP, close the discussion with key takeaways for payers to consider related to ruxolitinib and insights on future research.


Related to this article